Continental Investors Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$323K Buy
334
+22
+7% +$22.3K 0.31% 62
2025
Q4
$324K Buy
312
+18
+6% +$17.2K 0.42% 56
2025
Q3
$239K Buy
294
+15
+5% +$11.2K 0.35% 64
2025
Q2
$217K Buy
279
+10
+4% +$7.77K 0.39% 60
2025
Q1
$223K Buy
+269
New +$224K 0.44% 59

Other funds holding LLY

Continental Investors Services's LLY Position: Q1 2026 in Review

Continental Investors Services increased its Eli Lilly (LLY) stake by 7.1% in Q1 2026, buying an estimated $22.3K and bringing the position to 334 shares worth $323K. The position accounts for 0.31% of the portfolio, ranked #62.

Continental Investors Services first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $324K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Continental Investors Services held 334 shares of Eli Lilly worth $323K as of Q1 2026.
  • Continental Investors Services bought 22 Eli Lilly shares in Q1 2026, an estimated $22.3K.
  • Eli Lilly made up 0.31% of Continental Investors Services's portfolio in Q1 2026, its #62 holding.
  • Continental Investors Services first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Continental Investors Services's Eli Lilly position peaked at $324K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Continental Investors Services's 13F filing for Q1 2026, filed 15 May 2026.